Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Low-level light/laser therapy is effective in treating male and female pattern hair loss without side effects.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Surgical face-lifts are more effective, but fractional radiofrequency is a good, less invasive alternative for treating skin laxity.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

The 810-nm diode laser improves skin texture in keratosis pilaris but not redness.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

SIM01 significantly reduced post-COVID symptoms and is safe.

Women with PCOS are much more likely to experience depression.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.